Briakinumab (Anti-IL-12) (IL-12a & IL-12b)
Selected Variant
C00684-1mg*25
Size: 25x 1mg
Product Specifications
CAS Number
339308-60-0
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Briakinumab (anti-IL-12) (IL-12a & IL-12b) is a human monoclonal antibody directed against the human interleukins 12 (IL-12) and 23 (IL-23), with immunomodulating activity. It has the potential to be used in the treatment of Crohn's disease. MW: 143.86 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1907-100 1x 100 µL
STAT3 / Signal Transducer and Activator of Transcription 3 (PCRP-STAT3-2F12), 0.2mg/mL
Sign In for Pricing
View Details 
A11267-1-Dylight550 100 µg
Anti-ZNF318 Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details 
BNUB0019-100 1x 100 µL
Human Lambda Light Chain (ICO-106), 0.2mg/mL
Sign In for Pricing
View Details 
AZA0A0R4ILA8 100 µg/Vial
Anti-Zebrafish TBP-1/PSMC3 Antibody Picoband®
Sign In for Pricing
View Details 
BNC680047-100 1x 100 µL
Plasma Cell Marker (LIV3G11, same as 7B18), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details